Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
Basic & Clinical Pharmacology & Toxicology|June 15, 2026
The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational PerspectiveMirjam Wolfschlag, Elena Espa, Kevin Oliveira Hauer, et al.
Movement Disorders Clinical Practice|May 13, 2021
Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's DiseaseKristina Rosqvist, Per Odin, Stefan Lorenzl, et al.
Movement Disorders Clinical Practice|May 7, 2020
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 ExperienceAlfonso Fasano, Angelo Antonini, Regina Katzenschlager, et al.
Neurobiology of Aging|February 5, 2015
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyRuben Smith, Kit Wu, Thomas Hart, et al.
Brain and Behavior|September 3, 2021
Effects of safinamide on pain in patients with fluctuating Parkinson's diseaseSotirios Grigoriou, Pablo Martínez-Martín, K Ray Chaudhuri, et al.
Journal of Parkinson'S Disease|December 8, 2015
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's DiseaseMareike Fauser, Matthias Löhle, Georg Ebersbach, et al.
Journal of Geriatric Psychiatry and Neurology|January 17, 2024
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's DiseaseJennifer S Pigott, Bastiaan R Bloem, Stefan Lorenzl, et al.
NPJ Parkinson'S Disease|February 22, 2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi ConsensusFabrizio Stocchi, Angelo Antonini, Daniela Berg, et al.
Clinical Neuropharmacology|July 24, 2012
Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effectsPrashanth Reddy, Pablo Martinez-Martin, Alexandra Rizos, et al.
BMC Neurology|November 7, 2018
Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort studyMonika Balzer-Geldsetzer, Joaquim Ferreira, Per Odin, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Basic & Clinical Pharmacology & Toxicology|June 15, 2026
The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational PerspectiveMirjam Wolfschlag, Elena Espa, Kevin Oliveira Hauer, et al.
Movement Disorders Clinical Practice|May 13, 2021
Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's DiseaseKristina Rosqvist, Per Odin, Stefan Lorenzl, et al.
Movement Disorders Clinical Practice|May 7, 2020
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 ExperienceAlfonso Fasano, Angelo Antonini, Regina Katzenschlager, et al.
Neurobiology of Aging|February 5, 2015
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography studyRuben Smith, Kit Wu, Thomas Hart, et al.
Brain and Behavior|September 3, 2021
Effects of safinamide on pain in patients with fluctuating Parkinson's diseaseSotirios Grigoriou, Pablo Martínez-Martín, K Ray Chaudhuri, et al.
Journal of Parkinson'S Disease|December 8, 2015
Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's DiseaseMareike Fauser, Matthias Löhle, Georg Ebersbach, et al.
Journal of Geriatric Psychiatry and Neurology|January 17, 2024
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's DiseaseJennifer S Pigott, Bastiaan R Bloem, Stefan Lorenzl, et al.
NPJ Parkinson'S Disease|February 22, 2022
Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi ConsensusFabrizio Stocchi, Angelo Antonini, Daniela Berg, et al.
Clinical Neuropharmacology|July 24, 2012
Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effectsPrashanth Reddy, Pablo Martinez-Martin, Alexandra Rizos, et al.
BMC Neurology|November 7, 2018
Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort studyMonika Balzer-Geldsetzer, Joaquim Ferreira, Per Odin, et al.
Pageof 17